Increased expression of CX43 on stromal cells promotes leukemia apoptosis

Oncotarget

Volumn 6, Issue 42, 2015, Pages 44323-44331

  Yang, Shijie ^a,b   Wen, Qin ^a,b   Liu, Yao ^a,b   Zhang, Cheng ^a,b   Wang, Maihong ^b   Chen, Guo ^b   Gong, Yi ^b   Zhong, Jiangjian ^c   Chen, Xuelian ^a   Stucky, Andres ^a   Zhong, Jiang F ^a   Zhang, Xi ^a,b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

^c Z Genetic Medicine LLC   (United States)

Author keywords

Apoptosis; Bone marrow stromal cells; Leukemia

Indexed keywords

CASPASE 3; CASPASE 7; CONNEXIN 43; CYCLOPHOSPHAMIDE; CASPASE; GJA1 PROTEIN, HUMAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL COMMUNICATION; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE REGULATION; CELL PROLIFERATION; CONTROLLED STUDY; EPIGENETICS; FEMALE; FLUORESCENCE RECOVERY AFTER PHOTOBLEACHING; GAP JUNCTION; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA; MINIMAL RESIDUAL DISEASE; MORTALITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STROMA CELL; SURVIVAL RATE; SURVIVAL TIME; TUMOR MICROENVIRONMENT; ANIMAL; CELL CULTURE; CELL CYCLE CHECKPOINT; COCULTURE; CORD BLOOD STEM CELL TRANSPLANTATION; CYTOLOGY; ENZYME ACTIVATION; FETUS BLOOD; GENETIC TRANSFECTION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; NEOPLASMS, EXPERIMENTAL; PARACRINE SIGNALING; PATHOLOGY; RECURRENT DISEASE; TIME FACTOR; UPREGULATION;

ANIMALS; APOPTOSIS; CASPASES; CELL CYCLE CHECKPOINTS; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; CONNEXIN 43; CORD BLOOD STEM CELL TRANSPLANTATION; ENZYME ACTIVATION; FEMALE; FETAL BLOOD; GAP JUNCTIONS; HUMANS; LEUKEMIA; MESENCHYMAL STROMAL CELLS; MICE; NEOPLASMS, EXPERIMENTAL; PARACRINE COMMUNICATION; RECURRENCE; TIME FACTORS; TRANSFECTION; UP-REGULATION;

EID: 84953426244     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.6249     Document Type: Article

References (34)

1. Spengeman JD, Green TD, McCubrey JA, Bertrand FE. Activated EGFR promotes the survival of B-lineage acute leukemia in the absence of stromal cells. Cell Cycle. 2005; 4:483-487.
2. Liu Y, Chen XH, Si YJ, Li ZJ, Gao L, Zhang C, Zhang X. Reconstruction of hematopoietic inductive microenvironment after transplantation of VCAM-1-modified human umbilical cord blood stromal cells. PLoS One. 2012; 7:e31741.
3. Oyamada M, Oyamada Y, Takamatsu T. Regulation of connexin expression. Biochim Biophys Acta. 2005; 1719:6-23.
4. Saez JC, Berthoud VM, Branes MC, Martinez AD, Beyer EC. Plasma membrane channels formed by connexins: their regulation and functions. Physiol Rev. 2003; 83:1359-1400.
5. Kawasaki Y, Kubomoto A, Yamasaki H. Control of intracellular localization and function of Cx43 by SEMA3F. J Membr Biol. 2007; 217:53-61.
6. Upham BL, Park JS, Babica P, Sovadinova I, Rummel AM, Trosko JE, Hirose A, Hasegawa R, Kanno J, Sai K. Structure-activity-dependent regulation of cell communication by perfluorinated fatty acids using in vivo and in vitro model systems. Environ Health Perspect. 2009; 117:545-551.
7. Zhang W, Li HG, Fan MJ, Lv ZQ, Shen XM, He XX. Expressions of connexin 32 and 26 and their correlation to prognosis of non-small cell lung cancer. Ai Zheng. 2009; 28:173-176.
8. Forster T, Rausch V, Zhang Y, Isayev O, Heilmann K, Schoensiegel F, Liu L, Nessling M, Richter K, Labsch S, Nwaeburu CC, Mattern J, Gladkich J, Giese N, Werner J, Schemmer P, et al. Sulforaphane counteracts aggressiveness of pancreatic cancer driven by dysregulated Cx43-mediated gap junctional intercellular communication. Oncotarget. 2014; 5:1621-1634.
9. Leithe E, Sirnes S, Omori Y, Rivedal E. Downregulation of gap junctions in cancer cells. Crit Rev Oncog. 2006; 12:225-256.
10. Anand RJ, Hackam DJ. The role of gap junctions in health and disease. Crit Care Med. 2005; 33:S535-538.
11. Kandouz M, Bier A, Carystinos GD, Alaoui-Jamali MA, Batist G. Connexin43 pseudogene is expressed in tumor cells and inhibits growth. Oncogene. 2004; 23:4763-4770.
12. Li Z, Zhou Z, Welch DR, Donahue HJ. Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs. Clin Exp Metastasis. 2008; 25:893-901.
13. Liu Y, Zhang X, Li ZJ, Chen XH. Up-regulation of Cx43 expression and GJIC function in acute leukemia bone marrow stromal cells post-chemotherapy. Leuk Res. 2010; 34:631-640.
14. Kanczuga-Koda L, Sulkowski S, Tomaszewski J, Koda M, Sulkowska M, Przystupa W, Golaszewska J, Baltaziak M. Connexins 26 and 43 correlate with Bak, but not with Bcl-2 protein in breast cancer. Oncol Rep. 2005; 14:325-329.
15. Laird DW, Fistouris P, Batist G, Alpert L, Huynh HT, Carystinos GD, Alaoui-Jamali MA. Deficiency of connexin43 gap junctions is an independent marker for breast tumors. Cancer Res. 1999; 59:4104-4110.
16. Huang RP, Hossain MZ, Huang R, Gano J, Fan Y, Boynton AL. Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cells. Int J Cancer. 2001; 92:130-138.
17. Trosko JE, Ruch RJ. Gap junctions as targets for cancer chemoprevention and chemotherapy. Curr Drug Targets. 2002; 3:465-482.
18. Hirschi KK, Xu CE, Tsukamoto T, Sager R. Gap junction genes Cx26 and Cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential. Cell Growth Differ. 1996; 7:861-870.
19. Zhang X, Liu Y, Si YJ, Chen XH, Li ZJ, Gao L, ZhangC. Effect of Cx43 gene-modified leukemic bone marrow stromal cells on the regulation of Jurkat cell line in vitro. Leuk Res. 2012; 36:198-204.
20. Bigelow K, Nguyen TA. Increase of gap junction activities in SW480 human colorectal cancer cells. BMC Cancer. 2014; 14:502-502.
21. Abbaci M, Barberi-Heyob M, Stines JR, Blondel W, Dumas D, Guillemin F, Didelon J. Gap junctional intercellular communication capacity by gap-FRAP technique: a comparative study. Biotechnol J. 2007; 2:50-61.
22. Wade MH, Trosko JE, Schindler M. A fluorescence photobleaching assay of gap junction-mediated communication between human cells. Science. 1986; 232:525-528.
23. Bodi E, Hurtado SP, Carvalho MA, Borojevic R, Carvalho AC. Gap junctions in hematopoietic stroma control proliferation and differentiation of blood cell precursors. An Acad Bras Cienc. 2004; 76:743-756.
24. Zhang C, Chen XH, Zhang X, Gao L, Kong PY, PengXG, Liang X, Wang QY. Human umbilical cord blood-derived stromal cells: a new resource in hematopoietic reconstitution in mouse haploidentical transplantation. Transplant Proc. 2010; 42:3739-3744.
25. Hail N, Jr., Carter BZ, Konopleva M, Andreeff M. Apoptosis effector mechanisms: a requiem performed in different keys. Apoptosis : an international journal on programmed cell death. 2006; 11:889-904.
26. Lamkanfi M, Kanneganti TD. Caspase-7: a protease involved in apoptosis and inflammation. The international journal of biochemistry & cell biology. 2010; 42:21-24.
27. Solomon VR, Lee H. Chloroquine and its analogs: a new promise of an old drug for effective and safe cancer therapies. European journal of pharmacology. 2009; 625:220-233.
28. Fan C, Wang W, Zhao B, Zhang S, Miao J. Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells. Bioorganic & medicinal chemistry. 2006; 14:3218-3222.
29. Loehberg CR, Strissel PL, Dittrich R, Strick R, Dittmer J, Dittmer A, Fabry B, Kalender WA, Koch T, Wachter DL, Groh N, Polier A, Brandt I, Lotz L, Hoffmann I, KoppitzF, et al. Akt and p53 are potential mediators of reduced mammary tumor growth by cloroquine and the mTOR inhibitor RAD001. Biochemical pharmacology. 2012; 83:480-488.
30. Heiniger B, Gakhar G, Prasain K, Hua DH, Nguyen TA. Second-generation substituted quinolines as anticancer drugs for breast cancer. Anticancer research. 2010; 30:3927-3932.
31. Shishido SN, Prasain K, Beck A, Nguyen TD, Hua DH, Nguyen TA. Bioavailability and efficacy of a gap junction enhancer (PQ7) in a mouse mammary tumor model. PloS one. 2013; 8:e67174.
32. Perchellet EM, Crow KR, Gakhar G, Nguyen TA, Shi A, Hua DH, Perchellet JP. Bioactivity and molecular targets of novel substituted quinolines in murine and human tumor cell lines in vitro. International journal of oncology. 2010; 36:673-688.
33. Shishido SN, Delahaye A, Beck A, Nguyen TA. The anticancer effect of PQ1 in the MMTV-PyVT mouse model. Int J Cancer. 2014; 134:1474-1483.
34. Gao L, Chen X, Zhang X, Liu Y, Kong P, Peng X, Liu L, Liu H, Zeng D. Human umbilical cord blood-derived stromal cell, a new resource of feeder layer to expand human umbilical cord blood CD34+ cells in vitro. Blood Cells Mol Dis. 2006; 36:322-328.